Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.74 USD | +0.75% | +2.79% | +37.76% |
05-21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
05-20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.76% | 882M | |
+8.92% | 114B | |
+10.48% | 105B | |
-3.35% | 21.73B | |
-6.45% | 23.83B | |
-10.72% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Chardan Adjusts Immunome's Price Target to $9 From $16, Citing IMM-BCP-01 Launch Expectations, Stock Dilution From Future Capital Raises; Buy Rating Kept